GJL
INDV icon

Gendell Jeffrey L’s Indivior Pharmaceuticals INDV Stock Holding History

Gendell Jeffrey L’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.4M Hold
1,096,343
– – 0.46% 24
2025
Q4 		$39.3M Buy
1,096,343
+49,862
+5% +$1.52M 0.68% 14
2025
Q3 		$25.2M Buy
1,046,481
+190,000
+22% +$3.98M 0.46% 16
2025
Q2 		$12.6M Buy
856,481
+250,000
+41% +$2.91M 0.34% 11
2025
Q1 		$5.78M Buy
606,481
+303,218
+100% +$3.19M 0.25% 34
2024
Q4 		$3.77M Buy
+303,263
New +$3.12M 0.12% 59

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gendell Jeffrey L's INDV Position: Q1 2026 in Review

Gendell Jeffrey L held its Indivior Pharmaceuticals (INDV) position steady in Q1 2026 at 1,096,343 shares worth $33.4M. The position accounts for 0.46% of the portfolio, ranked #24.

Gendell Jeffrey L first reported a position in INDV in Q4 2024 and has held it in 6 quarters since. The position peaked at $39.3M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Gendell Jeffrey L held 1,096,343 shares of Indivior Pharmaceuticals worth $33.4M as of Q1 2026.
  • Gendell Jeffrey L left its Indivior Pharmaceuticals share count unchanged in Q1 2026.
  • Indivior Pharmaceuticals made up 0.46% of Gendell Jeffrey L's portfolio in Q1 2026, its #24 holding.
  • Gendell Jeffrey L first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Gendell Jeffrey L's Indivior Pharmaceuticals position peaked at $39.3M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Gendell Jeffrey L's 13F filing for Q1 2026, filed 15 May 2026.